Source: Wiley, by Neda Rafat; Hanhao Zhang; Josiah Rudge; Yoo Na Kim; Sai Preetham Peddireddy; Nabojeet Das; Aniruddh Sarkar (September 21, 2022). AI-generated summary by biochip.com, published . Not independently reviewed.
Key takeaways
- Georgia Tech and Emory researchers built a chip that detects Covid-19 antibodies from a finger-prick drop of blood using electrical conductivity.
- The multiplex chip can detect multiple antibody types and estimate antibody levels from the amount of silver deposited on its wells.
- The work does not establish clinical validation, diagnostic accuracy, regulatory status, or performance in routine patient testing.
Researchers at Georgia Tech and Emory University built a small electronic chip that detects Covid-19 antibodies from a single finger-prick drop of blood and sends the result to a smartphone. The device replaces the optical readout used in many laboratory antibody tests with an electrical measurement, turning a molecular binding event into a measurable circuit. Postdoctoral fellow Neda Rafat and Assistant Professor Aniruddh Sarkar developed the approach and reported the results in Small. Their chip uses silver deposits to bridge tiny wells on the sensor, allowing a basic multimeter to measure whether an electrical circuit has been completed. The team also designed multiplex versions of the chip that can detect more than one type of antibody in the same blood sample. That capability could let one chip screen for antibodies associated with Covid-19 and potentially other infections, including HIV or Lyme disease. Unlike many rapid tests, the approach is intended not only to identify antibodies but also to estimate their levels based on the amount of silver deposited on the chip. A Bluetooth reader and smartphone app developed by the team provide a practical route for displaying the results outside a conventional lab.
From Light-Based Tests to Electronic Signals
Many diagnostic tests work through a simple biological event: one molecule binds to another. In an antibody test, an antibody in a patient sample can bind to a target molecule placed on the test surface. Conventional laboratory methods often detect that binding with optics, meaning they use light-producing or color-changing reactions that must be read by specialized instruments.
Sarkar described the central change in the Georgia Tech and Emory design as making the binding event itself produce a direct electronic signal. Think of it like replacing a light bulb that signals “yes” with a switch that closes an electrical circuit. Rather than asking whether a chemical reaction creates enough light to see, the chip measures whether electrical conductivity has changed.
How Silver Completes the Circuit
The key material in Rafat's method is silver, a metal that conducts electricity efficiently. When the targeted antibody-binding process occurs in the chip's tiny wells, small deposits of silver form. Those deposits complete an electrical pathway that can be measured with a simple multimeter.
That design matters because it moves the signal closer to the electronics that read it. A multimeter is a familiar tool for checking whether a wire or household circuit carries electricity. Here, the same basic concept becomes a diagnostic readout: the sensor converts a molecular interaction in blood into a change in electrical conductivity.
A Chip Designed for More Than One Antibody
The team created multiplex chips, meaning a single chip can test for multiple antibody types at once. Instead of running separate tests for separate targets, different areas of the chip can be set up to respond to different antibodies. One drop of blood could therefore provide several measurements.
This feature distinguishes the platform from a test designed around just one biological marker. The researchers said the chip could potentially screen for multiple infections, including Covid-19, HIV, and Lyme disease. Its broader value lies in the underlying sensing format, which is built around electrically reading antibody interactions rather than relying on a separate optical instrument for every measurement.
Measuring Antibody Levels
The chip is also intended to quantify antibodies, not simply report a positive or negative result. In plain terms, it aims to show how much of a target antibody is present rather than only whether the antibody crosses a detection threshold. The researchers link that measurement to the amount of silver that accumulates on the sensor.
That relationship gives the platform a potentially useful extra layer of information. More silver on the chip means a stronger electrical effect, which the system can use to estimate antibody level. The work therefore combines three functions in one small format: detecting an antibody, distinguishing among multiple antibody targets, and measuring the relative amount detected.
From Sensor to Smartphone
The prototype system includes a Bluetooth reader and smartphone app that display test results. This reader acts as the bridge between the chip's electrical output and a format a user can view on a phone. Such a setup could reduce the need to interpret faint lines or color changes by eye.
The smartphone component also fits the team's effort to make the measurement simple and inexpensive. The chip does not eliminate the biological chemistry required for an antibody test, but it changes how the outcome is captured. By using conductivity and basic electronic measurement, the system points toward diagnostic tools that could be more compact than equipment-heavy laboratory workflows.
Why This Matters
Antibody testing has an important role in understanding whether a person's immune system has encountered a particular target, but the measurement technology can be complicated. Optical laboratory assays are highly established, yet they often depend on dedicated readers and light-based detection steps. The Georgia Tech and Emory chip explores a different route: use the chemistry of antibody binding, then read its result electronically.
The platform's multiplex capability is especially important because blood samples are limited, particularly when obtained by finger prick. A test that can examine several antibody targets from one drop could simplify screening workflows and reduce the number of separate measurements needed. Its ability to estimate antibody levels adds another dimension beyond a binary result.
What Comes Next
The reported work establishes an electronic antibody-sensing approach built around silver deposition, small chip wells, and smartphone-readable electronics. The team has shown how the same basic platform could be adapted to different infection-related antibody targets, while retaining a single-drop blood format. Future development will determine how the method performs across broader testing settings and how its quantitative electrical readout can be translated into practical diagnostic use.
Topics: Diagnostics & precision medicine · Infectious diseases
Start here: What is a biochip?